文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气下纤维支气管镜检查的呼吸机参数设置:一项随机、裁定者盲法对照试验VentSetFib

Ventilator settings for fiberoptic bronchoscopy during mechanical ventilation: a randomized adjudicator-blinded controlled trial VentSetFib.
PubMed 文献 · Crit Care · 2026-01-27
一句话结论对机械通气成人行纤维支气管镜检查时,采用优化呼吸机设置(吸气流量≤25L/min、潮气量5mL/kg等)可显著减少需提前终止的严重不良事件(4% vs 96%)。

单中心随机裁定者盲法对照试验纳入插管成人行纤维支气管镜检查者,1:1分配至优化设置组(吸气流量≤25L/min、潮气量5mL/kg、吸气时间1-1.3s、呼吸频率16次/分、呼气末正压5cmH2O)或常规设置组。主要复合终点(需提前终止的严重不良事件)优化组1/23(4%)vs常规组22/23(96%),风险差-91.3%,风险比0.05,p<0.001。事件主要由压力报警限制导致的通气失败驱动,常规设置下潮气量中位数160 vs 400mL、分钟通气量3.2 vs 7.2L/min。19例交叉患者中,切换至优化设置后峰值气道压降低并恢复充分通气。

要点

  • 优化设置组主要复合终点1/23(4%)vs常规组22/23(96%),风险差-91.3%,风险比0.05,p<0.001。
  • 事件主要由压力报警限制导致的通气失败驱动,常规设置下潮气量中位数160 vs 400mL(p<0.001)。
  • 常规设置下分钟通气量中位数3.2 vs 7.2L/min(p<0.001),优化设置组更高。
  • 优化设置:吸气流量≤25L/min、潮气量5mL/kg、吸气时间1-1.3s、呼吸频率16次/分、呼气末正压5cmH2O。
  • 19例交叉患者中,切换至优化设置后峰值气道压降低并恢复充分通气。

适用人群与场景

  • 接受机械通气的插管成人患者,行纤维支气管镜检查。

处置流程与药物剂量

  • 优化呼吸机设置:吸气流量≤25L/min、潮气量5mL/kg、吸气时间1-1.3s、呼吸频率16次/分、呼气末正压5cmH2O。
  • 常规设置组按常规呼吸机参数进行纤维支气管镜检查。

红旗征与不能漏的情况

  • 压力报警限制导致通气失败,表现为潮气量中位数160 vs 400mL、分钟通气量3.2 vs 7.2L/min(常规设置组)。
  • 需提前终止的严重不良事件包括无法提供通气支持、显著动脉血氧饱和度下降或血流动力学不稳定。

研究设计与关键结果

  • 单中心随机裁定者盲法对照试验,纳入插管成人行纤维支气管镜检查者,1:1分配至优化设置组(n=23)或常规设置组(n=23),意向性分析。
  • 主要复合终点(需提前终止的严重不良事件)优化组1/23(4%)vs常规组22/23(96%),风险差-91.3%,风险比0.05,p<0.001。
  • 常规设置下潮气量中位数160 vs 400mL(p<0.001),分钟通气量中位数3.2 vs 7.2L/min(p<0.001)。
  • 呼吸和循环事件罕见且两组相似(各1/23[4%])。
  • 19例交叉患者中,切换至优化设置后峰值气道压降低并恢复充分通气。

证据类型、等级与局限

  • 证据类型:单中心随机裁定者盲法对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对机械通气成人行纤维支气管镜检查时,采用优化呼吸机设置(吸气流量≤25L/min、潮气量5mL/kg、吸气时间1-1.3s、呼吸频率16次/分、呼气末正压5cmH2O)可减少压力报警限制导致的通气失败和需提前终止的严重不良事件。
  • 常规设置下潮气量中位数160 vs 400mL、分钟通气量3.2 vs 7.2L/min,优化设置组潮气量和分钟通气量更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: During bronchoscopy in mechanically ventilated patients, bronchoscope insertion markedly increases airway resistance, elevating peak airway pressure and reducing delivered tidal volume. We sought to determine whether specific ventilator settings (assist volume-controlled with reduced inspiratory flow and tidal volume) lower serious adverse events during flexible fiberoptic bronchoscopy compared with conventional ventilator settings.

METHODS: Single-center randomized adjudicator-blinded controlled trial in intubated adult patients undergoing fiberoptic bronchoscopy. Patients were assigned (1:1) to bronchoscopy-optimized settings (inspiratory flow ≤ 25L/min, tidal volume = 5mL/Kg, 1s ≤ inspiratory time ≤ 1.3s, respiratory frequency = 16 breaths/min, positive end-expiratory pressure = 5cmH2O) or to conventional ventilator settings. The primary endpoint was a composite of serious adverse events requiring premature termination (inability to deliver ventilatory support, significant arterial desaturation, or hemodynamic instability), adjudicated by blinded experts. All analyses were performed on an intention-to-treat basis.

RESULTS: The primary composite endpoint occurred in 1/23 (4%) with optimized settings compared with 22/23 (96%) with conventional settings (risk difference -91.3%; risk ratio 0.05; p < 0.001). Events were driven by ventilatory failure due to pressure-alarm limitation, with lower delivered tidal volume (median 160 vs 400 mL; p < 0.001) and minute ventilation (3.2 vs 7.2 L/min; p < 0.001) under conventional settings. Respiratory and circulatory events were rare and similar between groups (each 1/23 [4%]). Among 19 crossover patients, switching to optimized settings reduced peak airway pressure and restored adequate ventilation.

CONCLUSIONS: A bronchoscopy-optimized ventilation strategy substantially reduces pressure-alarm-limited ventilation events and enables the delivery of adequate ventilatory support during fiberoptic bronchoscopy.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lemyze M, Marshall DC, Granier M, et al. Ventilator settings for fiberoptic bronchoscopy during mechanical ventilation: a randomized adjudicator-blinded controlled trial VentSetFib. Crit Care. 2026. PMID: 41593766. doi:10.1186/s13054-026-05847-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。